James Kelly Ganjei
Director · Inmune Bio, Inc.
Individual
- 2024
- Dec 2, 2025
- 3
Filings (90d)
Other insiders active in the same sector
No other insider has filed at James Kelly Ganjei's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Emily M. Leproust - $101.55M in TWST purchases and sales in the last 12 months
- Bruce Booth - $100.59M in KYMR purchases and sales in the last 12 months
- Paul A. Mahon - $98.73M in UTHR purchases and sales in the last 12 months
- Herriot Tabuteau - $97.80M in AXSM purchases and sales in the last 12 months
- IGNITE AGGREGATOR LP - $92.50M in INNV purchases and sales in the last 12 months
- TCO GROUP HOLDINGS, L.P. - $92.50M in INNV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James Kelly Ganjei?
James Kelly Ganjei is a corporate insider, tracked as Director of Inmune Bio, Inc. (INMB). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did James Kelly Ganjei last file a Form 4?
The most recent primary Form 4 on record is dated 2 December 2025, one of 3 filings going back to 2024.